ERO backstop funding not needed
Company: Core Scientific
The claim, verbatim
The final ERO results make the previously arranged backstop funding for the offering unnecessary.
Source (primary)
core-scientific 8-K exhibit (d109221dex992.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-15)Live source ↗
Quote: “The final results of the offering render the previously arranged ERO backstop funding unnecessary”
How we checked this
Checked on November 16, 2026. The cited source supports every part of this claim.
The release directly states that the final results render the previously arranged ERO backstop funding unnecessary.
Confirmed in the source:
- The final results of the Equity Rights Offering make the previously arranged backstop funding unnecessary
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312524004018/d109221dex992.htm) in full (6,982 characters, retrieved November 15, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (d109221dex992.htm)
Quote: “The final results of the offering render the previously arranged ERO backstop funding unnecessary”